Clarivate Plc Ordinary Shares (CLVT)

FairStock Score: 59/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn good returns on capital and can be bought at a sensible price. Clarivate has some attractive raw material: Web of Science, ProQuest, and its patent and life-science data sit inside customer workflows, which can create switching costs. But the financial record is poor. In FY2023, the year ended 2023-12-31, net income was -$911.2M and diluted EPS was -$1.47. In FY2024, the year ended 2024-12-31, the net loss was -$636.7M, or -$0.96 per diluted share. In FY2025, the year ended 2025-12-31, revenue was $2.5B and the net loss was -$201.1M, or -$0.30 per diluted share. The loss is shrinking, but it is still a loss. In fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $585.5M, net income was -$40.2M, and diluted EPS was -$0.06. Revenue is not growing: FY2025 revenue of $2.5B was below FY2024's $2.6B, and Q1 2026 revenue was below Q1 2025's $593.7M. On the positive side, trailing free cash flow is $327.6M, a 32.0% FCF yield against the $1.0B market cap at the 2026-10-13 close. FairStock's P/B is 0.23 and EV/EBITDA is 7.60. Those are Graham-like cheapness signals. But FairStock's Altman Z is -0.90, D/E is 0.94, ROE is -7.01%, and ROCE is 0.94%. So the equity is a leveraged call option on stabilizing revenue and durable cash flow. The price may be cheap, but only if debt and losses do not consume the equity.

In plain English: Clarivate sells research, patent, and life-science information to universities, governments, and companies. The business generates cash but has lost money for years and sales have been slipping. At $1.60 a share, the market price looks very cheap compared with its cash flow and assets, but that cheapness comes with high debt and real risk.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer